VYCERITY Trademark

Trademark Overview


On Tuesday, September 14, 2021, a trademark application was filed for VYCERITY with the United States Patent and Trademark Office. The USPTO has given the VYCERITY trademark a serial number of 97026711. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Thursday, July 4, 2024. This trademark is owned by Neurocrine Biosciences, Inc.. The VYCERITY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for human use for treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, tardive dyskinesia, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro-immunological and neuro-endocrinological diseases, disorders, and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic a...
vycerity

General Information


Serial Number97026711
Word MarkVYCERITY
Filing DateTuesday, September 14, 2021
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateThursday, July 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and Servicespharmaceutical preparations for human use for treatment of Huntington's Disease, chorea associated with Huntington's Disease, schizophrenia, adjunctive treatment of schizophrenia, cognitive impairment associated with schizophrenia, epilepsy, epileptic encephalopathy with continuous spike-and-wave during sleep, SCN8A-related epilepsy with encephalopathy, focal onset seizures, tardive dyskinesia, Parkinson's Disease, adjunctive treatment of Parkinson's Disease, Major Depressive Disorder, anhedonia in Major Depressive Disorder, inadequate response to treatment in Major Depressive Disorder, dyskinetic cerebral palsy, and neuro-immunological and neuro-endocrinological diseases, disorders, and conditions; pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions of the neurological, hormonal, and endocrine systems; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia
Translation of Words in MarkThe wording VYCERITY has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateThursday, July 4, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurocrine Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Party NameNeurocrine Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events


Event DateEvent Description
Friday, September 17, 2021NEW APPLICATION ENTERED
Wednesday, October 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 8, 2022ASSIGNED TO EXAMINER
Thursday, June 9, 2022NON-FINAL ACTION WRITTEN
Thursday, June 9, 2022NON-FINAL ACTION E-MAILED
Thursday, June 9, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 6, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 7, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, February 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 7, 2023FINAL REFUSAL WRITTEN
Tuesday, February 7, 2023FINAL REFUSAL E-MAILED
Tuesday, February 7, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, February 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 15, 2023SUSPENSION LETTER WRITTEN
Wednesday, March 15, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, March 15, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, July 25, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, October 17, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, March 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 23, 2024EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Wednesday, July 3, 2024TEAS EXPRESS ABANDONMENT RECEIVED
Thursday, July 4, 2024ABANDONMENT - AFTER PUBLICATION
Thursday, July 4, 2024ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Wednesday, August 21, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED